Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | 13,341 | reported | 25 Feb 2026 | tx 65+204,325−26,579 |
| CYBRA CORP | 5,000 | reported | 19 Nov 2008 | tx 1+5,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1,250 | 0.00 USD | |
| 25 Feb 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 675 | 50.69 USD | |
| 25 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 1,250 | 0.00 USD | deriv |
| 24 Feb 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 603 | 51.35 USD | |
| 24 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1,125 | 0.00 USD | |
| 24 Feb 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 671 | 0.00 USD | |
| 24 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 750 | 0.00 USD | |
| 24 Feb 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 369 | 50.86 USD | |
| 24 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1,250 | 0.00 USD | |
| 24 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 1,125 | 0.00 USD | deriv |
| 24 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 1,250 | 0.00 USD | deriv |
| 24 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 750 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 13,500 | 0.00 USD | deriv |
| 25 Sept 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 1,875 | 0.00 USD | |
| 25 Sept 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 840 | 46.21 USD | |
| 25 Sept 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 1,875 | 0.00 USD | deriv |
| 10 Sept 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1,875 | 0.00 USD | deriv |
| 05 Mar 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 577 | 33.05 USD | |
| 05 Mar 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 314 | 33.05 USD | |
| 05 Mar 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 577 | 33.05 USD | |
| 21 Feb 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 1,875 | 0.00 USD | |
| 21 Feb 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 927 | 39.15 USD | |
| 23 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1,250 | 0.00 USD | |
| 22 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1,250 | 0.00 USD |